Professor Michael Douek

Professor Michael Douek

BASO~ACS President

Specialty Interest: Breast
Professor of Surgical Sciences and Breast Cancer
Nuffield Department of Surgical Sciences
University of Oxford

Professor Michael Douek has been a member of BASO since 1998 and served on BASO Council as an Ordinary Member since 2011 and as Meetings Secretary from 2015 to 2020. He was appointed BASO Honorary Secretary in 2020, was elected as BASO Vice-President in 2021 and succeeded as BASO President on 7th November 2023 for 2 years.

Professor Douek graduated from the University of Dundee (Scotland) and trained in surgery in London, Oxford and Cambridge. He obtained his MD from the University of London in 2000. In 2003, he was awarded a prestigious Health Foundation Clinician Scientist grant by the UK Academy of Medical Sciences, funding his joint Senior Lecturer and Consultant post at University College London, joining the only surgical oncology firm in the UK under the leadership of Professor Irving Taylor (Past-President of BASO, ESSO and Previous Editor-in-Chief of EJSO). In 2009, he moved to King's College London / Guy's & St Thomas' Hospitals where he was Professor of Surgical Oncology. In 2019 he was appointed as Rosetrees RCS Director of the Surgical Intervention Trials Unit and Professor of Surgical Sciences & Breast Cancer at the Nuffield Department of Surgical Sciences, University of Oxford.

Professor Douek is a breast cancer surgeon and surgical oncologist with a special interest in novel techniques for cancer surgery, breast reconstruction and clinical trials. He was awarded a Hunterian Professorship by the Royal College of Surgeons of England in 2015 and became Research Professor at the Royal College of Surgeons of England in 2019. He is passionate about clinical research and was chief investigator of numerous clinical trials including trials evaluating a magnetic technique for sentinel node biopsy, which he pioneered. Is is currently a chief investigator of the EndoNET Trial (NIHR / HTA funded national trial) a randomised controlled trial evaluating the effectiveness of neoadjuvant endocrine treatment in post-menopausal women with breast cancer.

Norwich Norfolk Website Design by 101
Website Design by 101
Contact | Privacy | Terms | Disclaimer | © Copyright